Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

The Risks of Outsourcing Medical Billing and the Importance of State-Law Compliance

Client Alert

Offshoring medical billing and other administrative functions can reduce costs, but it also raises significant compliance, operational, and contractual risks. Although HIPAA does not explicitly prohibit protected health information from being accessed or stored outside the United States, healthcare providers and their vendors remain responsible for safeguarding patient information and complying with state-specific restrictions that may limit or prohibit offshore subcontracting. 

For healthcare organizations, outsourcing billing can create exposure far beyond routine vendor-management issues. If an offshore billing company mishandles protected health information, submits inaccurate claims, or fails to follow applicable payer requirements, the provider, not just the vendor, may face delayed reimbursement, audit scrutiny, breach-response costs, contractual disputes, and reputational harm. 

HIPAA considerations

HIPAA protects protected health information (PHI), including individually identifiable health information maintained or transmitted by covered entities and business associates. Vendors that create, receive, maintain, or transmit PHI on behalf of a covered entity generally qualify as business associates and must comply with HIPAA’s applicable privacy and security obligations. 

At a minimum, organizations should confirm that outsourcing arrangements address:

  • appropriate access controls and role-based permissions;
  • encryption and other reasonable safeguards for PHI;
  • workforce training and documented compliance policies;
  • a compliant Business Associate Agreement (BAA);
  • audit rights, monitoring, and recordkeeping; and
  • clear breach reporting and notification procedures.

State-law and program requirements

HIPAA is only part of the analysis. State Medicaid rules, managed care agreements, provider manuals, executive orders, and other state authorities may impose additional restrictions on offshore subcontracting. In some jurisdictions, these restrictions can require that certain services be performed in the United States or that patient data remain within the country. As a result, a provider may be compliant with HIPAA yet still violate contract or state-specific requirements. 

This risk is especially important because enforcing contractual and privacy obligations against an offshore vendor may be incredibly difficult. When a foreign subcontractor experiences a breach or other compliance failure, the healthcare provider often bears the immediate burden of investigation, remediation, patient notification, and regulator response. 

Practical takeaways

Before outsourcing billing or related administrative functions overseas, providers should:

  • review state statutes, administrative codes, Medicaid guidance, and managed care contract requirements that may apply to the services at issue;
  • confirm whether any payer or provider agreement restricts subcontracting or offshore access to PHI;
  • conduct diligence on the vendor’s technical, administrative, and legal safeguards;
  • negotiate a BAA and service agreement with audit rights, indemnification, reporting obligations, and clear data-security requirements; and
  • implement ongoing monitoring to verify compliance after the arrangement begins.

For questions regarding the individualized risk requirements or assistance with compliance and implementation, please contact Amanda Waesch at alwaesch@bmdllc.com


Ohio Medicaid Extends Timely Filing Deadline Until 2025

The Ohio Department of Medicaid (ODM) recently announced that it is extending its timely filing deadline to February 28, 2025. According to ODM, roughly 2% of providers have contract issues preventing them from meeting the previous timely filing deadline of December 1, 2024.

Another Drug Manufacturer Pursues Rebate Program as 340B Alternative

Some of the nation’s largest drug manufacturers are forging ahead to implement rebate programs for 340B drugs, even after the federal government has called these programs illegal. While it is unclear how these federal courts will rule, this could threaten the sustainability of safety net providers and their patients.

Hurry Up, STOP. . .Has CTA Been Struck Down By Courts?

Following a recent case in Texas, uncertainty has arisen regarding whether clients should file "beneficial owners" reports. This is a result of the Federal Government enjoined from enforcing the CTA. Contact your BMD Member Blake Gerney to find out how this affects you.

DEA and HHS Issue its Third Extension of Telemedicine Flexibilities through 2025

The DEA and U.S. Department of Health and Human Services (HHS) have extended telemedicine flexibilities for prescribing controlled medications through December 31, 2025. This extension builds on temporary exceptions made in 2020 due to COVID-19, allowing providers to prescribe Schedule II-V controlled substances based on a telemedicine evaluation alone. The extension ensures continued patient access to necessary prescriptions and provides time for providers to comply with future regulations.

Medicare Making Changes to Improve Behavioral Health Care Access

The Centers for Medicare & Medicaid Services (CMS) has introduced changes to Medicare’s behavioral health coverage, including allowing Marriage and Family Therapists and Mental Health Counselors to enroll independently, increasing reimbursements for crisis psychotherapy and substance use treatment, and expanding services via community health workers. These updates address gaps in care and improve access to mental health services for Medicare beneficiaries.